Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Hepatocyte-specific deletion of Ppar promotes NAFLD in the context of obesity
Patients with MASLD or MASH may benefit from more structured monitoring, including non-invasive assessments of liver fibrosis such as FIB-4 index calculation or vibration-controlled transient elastography (FibroScan) when available
Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin: This can be both a serious and common side effect
Upcmld-dp133 276
US$ 20.18
US$ 20.80
US$ 20.17
US$ 26.84
US$ 25.14
US$ 22.00
US$ 27.66
US$ 28.86
